Two-Year Clinical, Angiographic, and Intravascular Ultrasound Follow-Up of the XIENCE V Everolimus-Eluting Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions: The SPIRIT II Trial
Bimmer E. Claessen, M. A. Beijk, V. Legrand, W. Ruzyllo, A. Manari, O. Varenne, M. J. Suttorp, Jan G.P. Tijssen, Karine Miquel‐Hébert, S. Veldhof, J. P.S. Henriques, Patrick W. Serruys, J. J. Piek (2009). Two-Year Clinical, Angiographic, and Intravascular Ultrasound Follow-Up of the XIENCE V Everolimus-Eluting Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions: The SPIRIT II Trial. Circulation Cardiovascular Interventions, 2(4), pp. 339-347, DOI: 10.1161/circinterventions.108.831800.
